These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 5720803)
21. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Fellowes ON Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794 [No Abstract] [Full Text] [Related]
22. Identification of established cell lines with reference to karyology. Moorhead PS Natl Cancer Inst Monogr; 1968 Dec; 29():45-50. PubMed ID: 4305438 [No Abstract] [Full Text] [Related]
23. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties. Foley GE Natl Cancer Inst Monogr; 1968 Dec; 29():217-28. PubMed ID: 4888929 [No Abstract] [Full Text] [Related]
24. Cells, vaccines, and the pursuit of precedent. Hilleman MR Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933 [No Abstract] [Full Text] [Related]
25. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines. Yerganian G; Nell MA; Cho SS; Hayford AH; Ho T Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757 [No Abstract] [Full Text] [Related]
26. Evidence for oncogenic properties of heteroploidy cell lines. Sanford KK Natl Cancer Inst Monogr; 1968 Dec; 29():283-7. PubMed ID: 5720798 [No Abstract] [Full Text] [Related]
27. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion. Sandberg AA Natl Cancer Inst Monogr; 1968 Dec; 29():233-6. PubMed ID: 5252583 [No Abstract] [Full Text] [Related]
28. Evidence for oncogenic properties of heteroploid cell lines--discussion. Moore AE Natl Cancer Inst Monogr; 1968 Dec; 29():291-2. PubMed ID: 4890060 [No Abstract] [Full Text] [Related]
29. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates--discussion. Stevenson RE Natl Cancer Inst Monogr; 1968 Dec; 29():333-4. PubMed ID: 4976361 [No Abstract] [Full Text] [Related]
30. Industrial production of primary tissue culture. Warren J Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363 [No Abstract] [Full Text] [Related]
31. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary. Sigel MM; von Magnus H Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867 [No Abstract] [Full Text] [Related]
33. The need for a standardised cell substrate for virus vaccine production. Perkins FT Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315 [No Abstract] [Full Text] [Related]
35. Evidence for oncogenic properties of primary cultures. Defendi V Natl Cancer Inst Monogr; 1968 Dec; 29():269-70. PubMed ID: 5720796 [No Abstract] [Full Text] [Related]
36. Tissue and medium antigens in vaccines. Coriell LL Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862 [No Abstract] [Full Text] [Related]
37. Tissue and medium antigens in vaccines--discussion. Feldman HA Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791 [No Abstract] [Full Text] [Related]